The Therapeutic Efficacy of Psilocybin in a Preclinical Model of Depressive- and Anxiety-Like Symptomology
April 12, 2022 Henry Chafee
<p><b>Depressive and anxiety disorders are debilitating psychiatric illnesses that affect a substantial portion of the world population. Current pharmaceutical interventions, such as selective serotonin reuptake inhibitors, are generally regarded as front-line treatments but are not universally effective at reducing symptomology. Psilocybin, the active component in Psilocybe cubensis mushrooms,...